{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:03:57Z","timestamp":1791144237798,"version":"4.1.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1097\/qco.0b013e328285a358","type":"journal-article","created":{"date-parts":[[2007,7,2]],"date-time":"2007-07-02T04:15:34Z","timestamp":1183349734000},"page":"399-407","source":"Crossref","is-referenced-by-count":80,"title":["The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the \u2018silo hypothesis\u2019"],"prefix":"10.1097","volume":"20","author":[{"given":"Robert H","family":"Rubin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210205","first-page":"573","article-title":"Infection in the organ transplant recipient","author":"Rubin","year":"2002"},{"key":"R2-10-20210205","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1086\/315391","article-title":"Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients","volume":"181","author":"Humar","year":"2000","journal-title":"J Infect Dis"},{"key":"R3-10-20210205","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/01.qco.0000136933.67920.dd","article-title":"Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients","volume":"17","author":"Pereyra","year":"2004","journal-title":"Curr Opin Infect Dis"},{"key":"R4-10-20210205","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/lt.21037","article-title":"Exploring the bidirectional interactions between human cytomegalovirus and hepatitis C virus replication after liver transplantation","volume":"13","author":"Nebbia","year":"2007","journal-title":"Liver Transpl"},{"key":"R5-10-20210205","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1399-3062.2006.00169.x","article-title":"Cytomegalovirus infection in renal transplant recipients","volume":"8","author":"Carstens","year":"2006","journal-title":"Transpl Infect Dis"},{"key":"R6-10-20210205","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/01.CIR.90.4.1969","article-title":"Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat","volume":"90","author":"Lemstrom","year":"1994","journal-title":"Circulation"},{"key":"R7-10-20210205","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1097\/00007890-199912270-00011","article-title":"Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients","volume":"68","author":"Humar","year":"1999","journal-title":"Transplantation"},{"key":"R8-10-20210205","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1161\/CIRCULATIONAHA.106.627570","article-title":"Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children","volume":"115","author":"Hussain","year":"2007","journal-title":"Circulation"},{"key":"R9-10-20210205","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1399-3046.2006.00641.x","article-title":"Subclinical cytomegalovirus and Epstein\u2013Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation","volume":"11","author":"Li","year":"2007","journal-title":"Pediatr Transplant"},{"key":"R10-10-20210205","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.healun.2005.11.449","article-title":"The cumulative effect of acute rejection on development of cardiac allograft vasculopathy","volume":"25","author":"Stoica","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R11-10-20210205","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ki.1993.234","article-title":"Infectious disease complications of renal transplantation [clinical conference]","volume":"44","author":"Rubin","year":"1993","journal-title":"Kidney Int"},{"key":"R12-10-20210205","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJM199004263221702","article-title":"Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts","volume":"322","author":"Soulillou","year":"1990","journal-title":"N Engl J Med"},{"issue":"Suppl 7","key":"R13-10-20210205","doi-asserted-by":"crossref","first-page":"S727","DOI":"10.1093\/clinids\/12.Supplement_7.S727","article-title":"Newer methods for diagnosis of cytomegalovirus infection","volume":"12","author":"Chou","year":"1990","journal-title":"Rev Infect Dis"},{"key":"R14-10-20210205","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/infdis\/160.1.16","article-title":"Neutralizing antibody responses to reinfecting strains of cytomegalovirus in transplant recipients","volume":"160","author":"Chou","year":"1989","journal-title":"J Infect Dis"},{"key":"R15-10-20210205","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/S0140-6736(00)02350-3","article-title":"Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation","volume":"355","author":"Emery","year":"2000","journal-title":"Lancet"},{"key":"R16-10-20210205","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1086\/315242","article-title":"Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation","volume":"181","author":"Sia","year":"2000","journal-title":"J Infect Dis"},{"key":"R17-10-20210205","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/S0140-6736(00)02350-3","article-title":"Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation","volume":"355","author":"Emery","year":"2000","journal-title":"Lancet"},{"key":"R18-10-20210205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1034\/j.1399-3062.1999.010306.x","article-title":"Diagnostic approach to cytomegalovirus infection in bone marrow and organ transplantation","volume":"1","author":"Griffiths","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"R19-10-20210205","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00007890-199409000-00007","article-title":"Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor","volume":"58","author":"Fietze","year":"1994","journal-title":"Transplantation"},{"key":"R20-10-20210205","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1099\/0022-1317-74-11-2333","article-title":"Tumour necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer\/promoter in immature monocytic cells","volume":"74","author":"Stein","year":"1993","journal-title":"J Gen Virol"},{"key":"R21-10-20210205","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/viro.1995.1143","article-title":"Stimulation of the human cytomegalovirus IE enhancer\/promoter in HL-60 cells by TNF-alpha is mediated via induction of NF\u03baB","volume":"208","author":"Prosch","year":"1995","journal-title":"Virology"},{"key":"R22-10-20210205","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0140-6736(94)91116-9","article-title":"Cytomegalovirus reactivation and tumour necrosis factor","volume":"343","author":"Docke","year":"1994","journal-title":"Lancet"},{"key":"R23-10-20210205","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/00007890-199705270-00007","article-title":"Enhanced (cytomegalovirus) viral replication associated with septic bacterial complications in liver transplant recipients","volume":"63","author":"Mutimer","year":"1997","journal-title":"Transplantation"},{"key":"R24-10-20210205","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/lt.500030505","article-title":"Enhanced (cytomegalovirus) viral replication after transplantation for fulminant hepatic failure","volume":"3","author":"Mutimer","year":"1997","journal-title":"Liver Transpl Surg"},{"key":"R25-10-20210205","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1086\/520307","article-title":"High incidence of active cytomegalovirus infection among septic patients","volume":"26","author":"Kutza","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R26-10-20210205","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1086\/520306","article-title":"Cytomegalovirus infection in patients with bacterial sepsis [editorial; comment]","volume":"26","author":"Ho","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R27-10-20210205","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1034\/j.1399-3062.1999.010304.x","article-title":"Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients","volume":"1","author":"Reinke","year":"1999","journal-title":"Trans Infect Dis"},{"key":"R28-10-20210205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM198207013070102","article-title":"Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients","volume":"307","author":"Quinnan","year":"1982","journal-title":"N Engl J Med"},{"key":"R29-10-20210205","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0002-9343(84)90655-7","article-title":"Importance of cytotoxic lymphocytes during cytomegalovirus infection in renal transplant recipients","volume":"76","author":"Rook","year":"1984","journal-title":"Am J Med"},{"key":"R30-10-20210205","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1182\/blood.V78.5.1373.1373","article-title":"Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease","volume":"78","author":"Reusser","year":"1991","journal-title":"Blood"},{"key":"R31-10-20210205","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJM198906293202605","article-title":"Severe herpesvirus infections in an adolescent without natural killer cells","volume":"320","author":"Biron","year":"1989","journal-title":"N Engl J Med"},{"key":"R32-10-20210205","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00007890-199201000-00013","article-title":"Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3","volume":"53","author":"Hibberd","year":"1992","journal-title":"Transplantation"},{"key":"R33-10-20210205","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00007890-200001150-00007","article-title":"An association between cytomegalovirus infection and chronic rejection after liver transplantation","volume":"69","author":"Evans","year":"2000","journal-title":"Transplantation"},{"key":"R34-10-20210205","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00007890-197712000-00010","article-title":"Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients","volume":"24","author":"Rubin","year":"1977","journal-title":"Transplantation"},{"key":"R35-10-20210205","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJM198605293142205","article-title":"Acquisition of donor strains of cytomegalovirus by renal-transplant recipients","volume":"314","author":"Chou","year":"1986","journal-title":"N Engl J Med"},{"key":"R36-10-20210205","first-page":"2126","article-title":"The source of cytomegalovirus infection in seropositive renal allograft recipients is frequently the donor kidney","volume":"19","author":"Grundy","year":"1987","journal-title":"Transplant Proc"},{"key":"R37-10-20210205","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(88)90685-X","article-title":"Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus","volume":"2","author":"Grundy","year":"1988","journal-title":"Lancet"},{"key":"R38-10-20210205","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1086\/315184","article-title":"The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients","volume":"181","author":"Nordoy","year":"2006","journal-title":"J Infect Dis"},{"key":"R39-10-20210205","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM199905133401903","article-title":"Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group","volume":"340","author":"Lowance","year":"1999","journal-title":"N Engl J Med"},{"key":"R40-10-20210205","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.100.1.61","article-title":"Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study","volume":"100","author":"Valantine","year":"1999","journal-title":"Circulation"},{"key":"R41-10-20210205","first-page":"25","article-title":"Role of CMV in transplant coronary artery disease and survival after heart transplantation","volume":"1","author":"Valantine","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"R42-10-20210205","first-page":"419","article-title":"Do mild infections trigger the rejection of renal allografts?","volume":"2","author":"Simmons","year":"1970","journal-title":"Transplant Proc"},{"key":"R43-10-20210205","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1086\/513948","article-title":"Cytomegalovirus disease and allograft loss after organ transplantation [editorial]","volume":"26","author":"Rubin","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"Suppl 7","key":"R44-10-20210205","doi-asserted-by":"crossref","first-page":"S827","DOI":"10.1093\/clinids\/12.Supplement_7.S827","article-title":"Vaccines for the prevention of human cytomegalovirus infection","volume":"12","author":"Plotkin","year":"1990","journal-title":"Rev Infect Dis"},{"key":"R45-10-20210205","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-114-7-525","article-title":"Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial","volume":"114","author":"Plotkin","year":"1991","journal-title":"Ann Intern Med"},{"key":"R46-10-20210205","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.ejca.2005.07.011","article-title":"Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center","volume":"41","author":"Torres","year":"2005","journal-title":"Eur J Cancer"},{"key":"R47-10-20210205","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1016\/j.transproceed.2005.07.013","article-title":"The role of early colonoscopy in CMV colitis of transplant recipients","volume":"37","author":"Korkmaz","year":"2005","journal-title":"Transplant Proc"}],"container-title":["Current Opinion in Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QCO.0b013e328285a358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:39:34Z","timestamp":1786034374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001432-200708000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qco.0b013e328285a358","relation":{},"ISSN":["0951-7375"],"issn-type":[{"value":"0951-7375","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}